MEK1-independent activation of MAPK and MEK1-dependent activation of p70 S6 kinase by stem cell factor (SCF) in ovarian cancer cells

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 385-389

  Liu, Lian ^a,b   Zhang, Xin ^a   Du, Chao ^b   Zhang, Xiaoning ^b   Hou, Nan ^b   Zhao, Di ^b   Sun, Jianzhi ^a   Li, Li ^a   Wang, Xiuwen ^a   Ma, Chunhong ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

MAPK; MEK; Ovarian cancer; Signal transduction; Stem cell factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; S6 KINASE; SMALL INTERFERING RNA; STEM CELL FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; KNOCKOUT GENE; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OVARIAN NEOPLASMS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA INTERFERENCE; STEM CELL FACTOR;

EID: 63349089160     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.031     Document Type: Article

References (32)

1. Orsulic S., Li Y., Soslow R.A., Vitale-Cross L.A., Gutkind J.S., and Varmus H.E. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1 (2002) 53-62
2. Maines-Bandiera S., Ong A., Roskelley C.D., and Auersperg N. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int. J. Cancer 85 (2000) 430-437
3. Bartlett J.M.S. Ovarian Cancer, Method and Protocols (2000), Humana Press
4. Yarden Y., Kuang W.J., Yang-Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U., and Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6 (1987) 3341-3351
5. Papadimitriou C.A., Topp M.S., Serve H., Oelmann E., Koenigsmann M., Maurer J., Oberberg D., Reufi B., Thiel E., and Berdel W.E. Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. Eur. J. Cancer 31A (1995) 2371-2378
6. Sekido Y., Takahashi T., Ueda R., Takahashi M., Suzuki H., Nishida K., Tsukamoto T., Hida T., Shimokata K., Zsebo K.M., et al. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res. 53 (1993) 1709-1714
7. Crosier P.S., Ricciardi S.T., Hall L.R., Vitas M.R., Clark S.C., and Crosier K.E. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82 (1993) 1151-1158
8. Savarese D.M., Valinski H., Quesenberry P., and Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34 (1998) 80-91
9. Inoue M., Kyo S., Fujita M., Enomoto T., and Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res. 54 (1994) 3049-3053
10. Wilczynski S.P., Chen Y.Y., Chen W., Howell S.B., Shively J.E., and Alberts D.S. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. Hum. Pathol. 36 (2005) 242-249
11. Shaw T.J., Keszthelyi E.J., Tonary A.M., Cada M., and Vanderhyden B.C. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression. Exp. Cell Res. 273 (2002) 95-106
12. Parrott J.A., Kim G., and Skinner M.K. Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biol. Reprod. 62 (2000) 1600-1609
13. Reddy P., Shen L., Ren C., Boman K., Lundin E., Ottander U., Lindgren P., Liu Y.X., Sun Q.Y., and Liu K. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev. Biol. 281 (2005) 160-170
14. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
15. Liu K. Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci. 1 (2006) 126-135
16. Organ C., Hines S.J., Kornstein M.J., and Krystal G.W. Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ. 6 (1995) 769-779
17. Takahashi T., Hibi K., Sekido Y., Ueda R., Hida T., Ariyoshi Y., Takagi H., and Takahashi T. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6 (1991) 2291-2296
18. Zhang W., Stoica G., Tasca S.I., Kelly K.A., and Meininger C.J. Modulation of tumor angiogenesis by stem cell factor. Cancer Res. 60 (2000) 6757-6762
19. Carbone A., Bellone G., Sibona N., Bosco O., Tibaudi D., Smirne C., Martone T., Gramigni C., Camandona M., Emanuelli G., and Rodeck U. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res. 61 (2001) 2200-2206
20. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., Sattler M., Johnson B.E., and Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-kit in small cell lung cancer cells. Cancer Res. 62 (2002) 6304-6311
21. Scholl S., Kirsch C., Bohmer F.D., and Klinger R. Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells. J. Cancer Res. Clin. Oncol. 130 (2004) 711-718
22. Wennstrom S., and Downward J. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol. Cell. Biol. 19 (1999) 4279-4288
23. Lin C.H., Yeh S.H., Lin C.H., Lu K.T., Leu T.H., Chang W.C., and Gean P.W. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31 (2001) 841-851
24. Gingery A., Bradley E., Shaw A., and Oursler M.J. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J. Cell Biochem. 89 (2003) 165-179
25. Kfir S., Ehrlich M., Goldshmid A., Liu X., Kloog Y., and Henis Y.I. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol. Cell. Biol. 25 (2005) 8239-8250
26. Duckworth B.C., and Cantley L.C. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength. J. Biol. Chem. 272 (1997) 27665-27670
27. Zimmermann S., and Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286 (1999) 1741-1744
28. Hindley A., and Kolch W. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell. Sci. 115 (1992) 1575-1581
29. Holt K.H., Kasson B.G., and Pessin J.E. Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase. Mol. Cell. Biol. 16 (1996) 577-583
30. Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4 (2004) 937-947
31. Sebolt-Leopold J.S., Dudley D.T., Herrera R., Van Becelaere K., Wiland A., Gowan R.C., Tecle H., Barrett S.D., Bridges A., Przybranowski S., Leopold W.R., and Saltiel A.R. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5 (1999) 810-816
32. Allen L.F., Sebolt-Leopold J., and Meyer M.B. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30 (2003) 105-116